Carbetocin nasal spray for Prader-Willi syndrome eating behaviors (open-label extension)
Treatments studied
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This is a long-term follow-up study for people who completed a previous study of carbetocin nasal spray for hyperphagia (extreme hunger) in Prader-Willi syndrome. The trial gives everyone the study drug openly to see if it continues to help manage eating behaviors over a longer period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have completed the 12-week treatment period and all visits in the earlier carbetocin study (Study ACP-101-302).
- Your doctor must believe you could benefit from continued treatment with carbetocin.
- You must live with a caregiver who understands the study rules and is willing to join all study visits with you.
- You must not have had a stroke, brain injury, epilepsy, or frequent migraines (fever-related seizures as a child are okay).
- You must not have active or past psychotic symptoms, a psychotic disorder, or a history of suicide attempt or psychiatric hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called RM-718 for people with severe obesity linked to a specific brain pathway (MC4R). It may help if your obesity is due to a brain injury or tumor affecting the hypothalamus, or if you have Prader-Willi syndrome.
This trial tests an investigational drug called CSTI-500 for people with Prader-Willi syndrome who are in the hyperphagia (constant hunger) phase. It aims to see if the drug can improve behavior and reduce overeating. You and your caregiver will need to visit the clinic regularly and answer questions about symptoms.
This trial tests an experimental drug called BMB-101 to see if it can help control extreme hunger in adults with Prader-Willi Syndrome. It aims to improve safety and quality of life.
This trial studies whether targeted brain stimulation (TMS) can help with appetite and eating feelings in people with Prader-Willi syndrome. It also includes an MRI scan to measure brain-related effects, but only if you can safely have these scans.
This study tests an oral medication, pitolisant, in people with Prader-Willi syndrome who have already been in a pitolisant study. It aims to see if continuing treatment is safe and effective.
This trial studies whether taking prebiotics and probiotics can help children with Prader-Willi syndrome manage obesity. It’s testing a gut-focused approach to weight control over the study period.
Hear when a new Hyperphagia in Prader-Willi Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.